Home  |  Contact

Cellosaurus HROG02 (CVCL_4U38)

[Text version]
Cell line name HROG02
Accession CVCL_4U38
Resource Identification Initiative To cite this cell line use: HROG02 (RRID:CVCL_4U38)
Comments From: Linnebacher M.; University of Rostock; Rostock; Germany.
Population: Caucasian.
Doubling time: 36-54 hours (CLS=300931).
Omics: Deep exome analysis.
Omics: HLA class I peptidome analysis by proteomics.
Omics: HLA class II peptidome analysis by proteomics.
Derived from site: In situ; Brain, right parieto-occipital lobe.
Sequence variations
HLA typing Source: PubMed=33592498
Class I
HLA-AA*01:01,02:01
HLA-BB*08:01,13:02
HLA-CC*06:02,07:01
Class II
HLA-DPDPA1*01:03
DPB1*04:01
HLA-DQDQA1*02:01,05:01
DQB1*02:01,02:02
HLA-DRDRB1*03:01,07:01
DRB3*01:01
DRB4*01:03
Disease Glioblastoma (NCIt: C3058)
Glioblastoma (ORDO: Orphanet_360)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_C6JW (HROG02-CIITA)
Sex of cell Male
Age at sampling 68Y
Category Cancer cell line
Publications

PubMed=23951083; DOI=10.1371/journal.pone.0071070
Mullins C.S., Schneider B., Stockhammer F., Krohn M., Classen C.F., Linnebacher M.
Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: a detailed comparison.
PLoS ONE 8:E71070-E71070(2013)

PubMed=33592498; DOI=10.1074/mcp.RA120.002201
Forlani G., Michaux J., Pak H., Huber F., Lauret Marie-Joseph E., Ramia E., Stevenson B.J., Linnebacher M., Accolla R.S., Bassani-Sternberg M.
CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens.
Mol. Cell. Proteomics 20:100032.1-100032.21(2021)

Cross-references
Cell line collections (Providers) CLS; 300931
Cell line databases/resources cancercelllines; CVCL_4U38
Encyclopedic resources Wikidata; Q54895307
Proteomic databases PRIDE; PXD020079
Entry history
Entry creation22-Sep-2015
Last entry update05-Oct-2023
Version number15